Cargando…
Oncology drug health technology assessment recommendations: Canadian versus UK experiences
BACKGROUND: Canada has two health technology assessment (HTA) agencies responsible for oncology drug funding recommendations: the Institut National d’Excellence en Santé et Services Sociaux (INESSS) for the province of Québec and the pan-Canadian Oncology Drug Review for the rest of Canada. The obje...
Autores principales: | Chabot, Isabelle, Rocchi, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4106959/ https://www.ncbi.nlm.nih.gov/pubmed/25075196 http://dx.doi.org/10.2147/CEOR.S66309 |
Ejemplares similares
-
Evolution of health technology assessment: best practices of the pan-Canadian Oncology Drug Review
por: Rocchi, Angela, et al.
Publicado: (2015) -
Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia
por: Ismail, Zahinoor, et al.
Publicado: (2020) -
A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada
por: Regier, Dean A., et al.
Publicado: (2022) -
Canadian National Guidelines and Recommendations for Integrating Career Advising Into Medical School Curricula
por: Howse, Kelly, et al.
Publicado: (2017) -
The importance of instrumental assessment in disorders of consciousness: a comparison between American, European, and UK International recommendations
por: Magnani, F. G., et al.
Publicado: (2022)